Results 141 to 150 of about 13,871 (164)

Copper–topotecan complexation mediates drug accumulation into liposomes

Journal of Controlled Release, 2006
Marcel Bally, Amandeep Singh Taggar, Euan Ramsay   +2 more
exaly  

Topotecan in the Treatment of Recurrent Small Cell Lung Cancer: An Update

Oncologist, 2004
Andrea Ardizzoni, Ardizzoni Andrea
exaly  

Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release

European Journal of Pharmaceutics and Biopharmaceutics, 2011
Valadares Mc, Ricardo Marreto, Rodolpho C Braga   +2 more
exaly  

Topotecan

Reactions Weekly, 2018
openaire   +1 more source

Topotecan

Der Onkologe, 1998
R. Kath, H. D. Peters, C.-P. Schneider, K. Höffken   +3 more
openaire   +1 more source

Development of a highly stable and targetable nanoliposomal formulation of topotecan

Journal of Controlled Release, 2010
Mark Hayes, Byron Hann, Dmitri Kirpotin   +2 more
exaly  

A Dose-Escalating Study of Weekly Bolus Topotecan in Previously Treated Ovarian Cancer Patients

Gynecologic Oncology, 2001
Luis Vaccarello, Howard D Homesley, H D Homesley   +2 more
exaly  

Urinary and fecal excretion of topotecan in patients with malignant solid tumours

Cancer Chemotherapy and Pharmacology, 2002
Jan Schellens, Rosing Hilde, Schellens Jan H   +2 more
exaly  

Glioma cell sensitivity to topotecan: the role of p53 and topotecan-induced DNA damage

European Journal of Pharmacology, 2001
Jörg Wischhusen, Michael Weller, Ulrike Naumann   +2 more
exaly  

Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma

European Journal of Cancer, 2011
Maria Antonietta De Ioris, Aurora Castellano, Alessandro Jenkner   +2 more
exaly